Pelviva has been designed to use innovative technology to provide a medical device that is easy to use, discreet and clinically effective.1
Designed to fit into women's busy lives.
Pelviva works by delivering a programme of neuromuscular electrical stimulation (NMES) to the female Pelvic Floor muscle via vaginal electrodes. The programme provides stimulation to both types of muscle fibre within the Pelvic Floor making Pelviva suitable for bladder leakage associated with stress, urgency and mixed incontinence.
Hover over the hot spot buttons to reveal Pelviva’s innovative technology
Measures every pulse and monitors the actual level of stimulation through the muscle. The feedback mechanism automatically adjusts the output upwards and downwards to maintain therapeutic target intensity.2
Pulses generated by the microprocessor are delivered to the pulse pads and are conducted via the vaginal mucosa to stimulate the Pelvic Floor muscle.2
Drives microprocessor
Soft & compressible for ease of insertion. Holds pulse pads in close contact with vaginal mucosa
Remove pull tab to activate battery
84% of women improved bladder control in a 12 week clinical study1
Four times greater improvement in quality of life1
Read about the Pelviva clinical data click here
The foam is soft, lightweight, and can be easily compressed to position Pelviva inside the vagina. It is designed to maximise comfort and product performance. The soft foam adjusts to differences in female anatomy. Once in position the Pelviva foam reforms and moulds to comfortably fit each individual shape holding the flexible pulse pads in close contact with the mucosal membrane of the vaginal walls.2
Unique feedback mechanism allows the user to be mobile during treatment whilst the microprocessor maintains a therapeutic level of stimulation. RPT allows the strength of the Pelviva treatment to be automatically adjusted in different women according to their own individual anatomy and how their body works.2
The soft compressible bio-compatible foam makes Pelviva comfortable & easy to use. The flexible pulse pads allow the user to move comfortably during treatment allowing women to remain active whilst using Pelviva.2
The unique Non-Uniform frequency pattern delivers low and moderate frequencies to target both types of muscle fibre in the same treatment.3
Each 30 minute treatment delivers an automated intensity with a feedback mechanism ensuring a therapeutic level of stimulation is delivered to the Pelvic Floor muscles.2
The Pelviva non-uniform frequency incorporates a doublet pulse at the beginning of each pulse train. This enables Pelviva to reach up to 25% greater depth than conventional stimulation.4,5
Varying inter-pulse intervals produce low and moderate frequency stimulation within each 1 second pulse. This reduces the risk of over fatiguing the muscle and allows Pelviva to treat both endurance and power fibres simultaneously.2
The first cycle (1 second) has a pulse width of 125 microseconds (this is half the width of the remaining pulses). This unique feature of the Pelviva stimulation pattern helps overcome the impact of tissue resistance and gives a comfortable introduction to treatment after a rest period. The second cycle has pulses that are 250 microseconds for full therapeutic effect and is repeated a further 9 times to create a 10 second continuous treatment cycle.2
This pattern of stimulation also includes a ‘doublet’ of 2 high frequency pulses. There is evidence to support that this doublet stimulates up to 25% more of the target muscle than would be achieved using uniform frequency stimulation. The constantly changing pattern of non uniform stimulation has been demonstrated to produce greater cortical awareness of muscle function than existing uniform stimulation patterns.4,6
The RPT™ feedback mechanism monitors each pulse to check the intensity that has been delivered to the muscle, adjusting the intensity upwards or downwards to reach and maintain the therapeutic target level.2
Pulses generated by the microprocessor are delivered to the pulse pads and through the vaginal mucosa to stimulate the Pelvic Floor muscle.
The returning pulse is monitored by a feedback mechanism to assess target intensity.2
